Device companies already enjoy big profit margins and are finding ways to avoid the impact of President Trump's tariffs.

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

The surgical robot maker is considering operational changes to counter tariff impacts on sales and demand but foresees no substantial benefits this year, Jamie Samath, chief finan ...

Surgical is warning that President Donald Trump's import taxes and retaliation from trade partners could have a significant ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...

Intuitive (Nasdaq: ISRG) announced two studies supporting the use of robotic-assisted surgery and its benefits to patients.

Medical devices, or the medtech sector, are not immune from the reciprocal tariffs announced by Trump yesterday.

While Intuitive is still reporting steady growth in the placement of its da Vinci surgical robots—as well as the number of procedures they have performed—the company said it expects to take a ...

RBC Capital lowered the firm’s price target on Intuitive Surgical (ISRG) to $630 from $670 and keeps an Outperform rating on the shares as part ...

October 17, 2024 Intuitive beats quarterly profit estimates on strong demand for surgical robots Medical device maker Intuitive Surgical beat Wall Street estimates for third-quarter profit on ...

(Reuters) - Medical device maker Intuitive Surgical said on Tuesday that U.S. tariffs will increasingly weigh on its business for the rest of the year, disrupting operations in China and ...